Aydin Huseynov analyst LADENBURG

Currently out of the existing stock ratings of Aydin Huseynov, 54 are a BUY (80.6%), 13 are a HOLD (19.4%).

Aydin Huseynov

Work Performance Price Targets & Ratings Chart

Analyst Aydin Huseynov, currently employed at LADENBURG, has had 42.27% of price targets met with an average potential upside of 74.15%, reached in 340 days on average. Previously, Aydin Huseynov worked at BENCHMARK.

Aydin Huseynov has documented 125 price targets and ratings displayed on 27 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ATHE, at 16-Jun-2026.

Wall Street Analyst Aydin Huseynov

Analyst best performing recommendations are on NRBO.
The best stock recommendation documented was for NRBO on 12/13/2022. The price target of $6 was fulfilled within 15 days with a profit of $7.2 (54.55%), with a performance score of 36.36.

Average potential price target upside

CALA INCY yte INO Inovio Pharmaceuticals NKTR REGN Regeneron Pharmaceuticals SLS SPRB VYGR NXTC NextCure ALLR ATHE CMPX PCSA TRIL PALI CRVS CGTX TPST Tempest Therapeutics CAPR Capricor Therapeutics MRKR Marker Therapeutics ACRV Acrivon Therapeutics ALRN IONS Ionis Pharmaceuticals CAL NRBO QNRX CLDI

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$2

$2

4 years 6 days ago
(15-Nov-2022)

3/4 (75%)

$-0.38 (-15.97%)

53

Buy

$8

4 years 2 months 23 days ago
(29-Aug-2022)

0/1 (0%)

$4.17 (108.88%)

Buy

$140

6 years 6 months 10 days ago
(11-May-2020)

0/2 (0%)

$3.2 (2.34%)

Buy

$340

$240

9 years 7 months 23 days ago
(29-Mar-2017)

3/3 (100%)

$110.33 (71.65%)

163

Show more analysts

Please expand the browser size to see the chart

Which stock is Aydin Huseynov most bullish on?

Potential upside of $8.48 has been obtained for ATHE

What Year was the first public recommendation made by Aydin Huseynov?

On 2020
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?